Browse > Article
http://dx.doi.org/10.5352/JLS.2005.15.3.406

Expression of DNA-dependent Protein Kinase and Its Relationship with Epidermal Growth Factor Receptor Signaling in Metastatic Cancer Cell Lines  

Hwang Jee Young (Department of Obstetrics & Gynecology, College of Medicine, Pusan National University)
Kim Sun Hee (Department of Biochemistry, College of Medicine, Pusan National University)
Kang Chi Dug (Department of Biochemistry, College of Medicine, Pusan National University)
Yoon Man Soo (Department of Obstetrics & Gynecology, College of Medicine, Pusan National University)
Publication Information
Journal of Life Science / v.15, no.3, 2005 , pp. 406-414 More about this Journal
Abstract
The genetic instability of cancer cells may be related to inappropriately activated DNA repair pathways. In present study, the modulated expression of DNA-dependent protein kinase (DNA-PK), a major DNA repair protein, in human cancer metastatic cells was tested. The expressions of Ku70/80, regulatory subunit of DNA-PK, and the Ku DNA-binding activity in various highly metastatic cell lines were higher than those in each parental cell line. Also, the expression of DNA-PKcs, catalytic subunit of DNA-PK, and the kinase activity of the whole DNA-PK complex in highly metastatic cells were significantly increased as compared to those of parental cells, suggesting that the enhanced DNA repair capacity of metastatic cells could be associated with aberrant use of DNA repair, which may mediate tumor progression and metastatic potential. Increased EGFR (epidermal growth factor receptor) signaling has been associated with tumor invasion and metastasis, and the linkage between EGFR-mediated signaling and DNA-PK has been suggested. This study showed that PKI166, the new EGFR tyrosine kinase inhibitor, modulated the expressions of Ku70/80 and DNA-PKcs and also revealed the chemosensitization effect of PKI166 against metastatic cells may be in part due to inhibition of Ku70/80. These results suggest that interference in EGFR signaling by EGFR inhibitor resulted in the impairment of DNA repair activity, and thus DNA-PK could be possible molecular targets for therapy against metastatic cancer cells.
Keywords
DNA-PK; EGFR; metastatic cell lines; chemosensitization; DNA repair;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Carpenter G. 1987. Receptors for epidermal growth factor and other polypeptide mitogens. Annu Rev Biochem. 56, 881-914   DOI   ScienceOn
2 Harris, A. J. 1985. DNA repair: relationship to drug and radiation resistance, metastasis and growth factors. Int. J. Radiat. BioI. Relat. Stud. Phys. Chem. Med. 45, 675-690
3 Usmani, B. A., J. Lunec and G. V. Sherbet. 1993. DNA repair and repair fidelity in metastatic variants of the B16 murine melanoma. J. Cell Biochem. 51, 336-344   DOI   ScienceOn
4 Yang, S. H., A. Nussenzweig, W. H. Yang, D. Kim and G. C. Li. 1996. Cloning and characterization of Rat Ku70: Involvement of Ku autoantigen in the heat-shock response. Rad. Res. 146, 603-611   DOI   ScienceOn
5 Kim, S. H., D. Kim, J. S. Han, C. S. Jeong, B. S. Chung, C. D. Kang and G. C. Li. 1999. Ku autoantigen affects the susceptibility to anticancer drugs. Cancer Res. 59, 4012-4017
6 Chen, W. S., C. S. Lazar, M. Poenie, R. Y. Tsien, G. N. Gill and M.G. Rosenfeld. 1987. Requirement for intrinsic protein tyrosine kinase in the immediate and late actions of the EGF receptor. Nature 328, 820-823   DOI   ScienceOn
7 Todaro, G. J., C. Fryling and J. E. De Larco. 1980. Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors. Proc. NatI. Acad. Sci. USA 77, 5258-5262
8 Hu, G., W. Liu, J. Mendelsohn, J. M. Ellis, R. Radinsky, M. Andreeff and A. B. Deisseroth. 1997. Expression of epidermal growth factor receptor and human papillomavirus E6/E7 proteins in cervical carcinoma cells. NatI. Cancer Inst. 89, 1271-1276   DOI   ScienceOn
9 Iihara, K., H. Shiozaki, H. Tahara, K. Kobayashi, M. Inoue, S. Tamura, M. Miyata, H. Oka, Y. Doki, and T. Mori. 1993. Prognostic significance of transforming growth factor-alpha in human esophageal carcinoma. Implication for the autocrine proliferation. Cancer 71, 2902-2909   DOI   ScienceOn
10 Grandis, J. R., M. F. Melhem, W. E. Gooding, R. Day, V. A. Holst, M. M. Wagener, S. D. Drenning and D. J. Tweardy. 1998. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival. NatI. Cancer Inst. 90, 824-832   DOI   ScienceOn
11 Klijn, J. G., P. M. Berns, P. J. Schmitz and J. A. Foekens. 1992. The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients. Endocr. Rev. 13, 3-17
12 Dickstein, B. M., K. Wosikowski and S. E. Bates. 1995. Increased resistance to cytotoxic agents in ZR75B human breast cancer cells transfected with epidermal growth factor receptor. Mol. Cell Endocrinol. 110, 205-211   DOI   ScienceOn
13 Balaban, N., J. Moni, M. Shannon, J. Dang, E. Murphy and T. Goldkom. 1996. The effect of ionizing radiation on signal transduction: antibodies to EGF receptor sensitize A431 cells to radiation. Biochim. Biophys. Acta 1314, 147-156   DOI   ScienceOn
14 Webb, C. P. and G. F. 2000. Vande Woude. Genes that regulate metastasis and angiogenesis. J. Neurooncol. 50, 71-87   DOI   ScienceOn
15 Wei, Q., J. Cheng, K. Xie, C. D. Bucana and Z. Dong. 1997. Direct correlation between DNA repair capacity and metastatic potential of K-1735 murine melanoma cells. J. Invest. Dermatol. 105, 3-6
16 Liang, Y., S. McDonnell and M. Clynes. 2002. Examining the relationship between cancer invasion/metastasis and drug resistance. Curr. Cancer Drug Targets 2, 257-277   DOI   ScienceOn
17 Kim, S. H., J. H. Um, D. W. Kim, B. H. Kwon, D. W. Kim, B. S. Chung and C. D. Kang. 2000. Potentiation of chemosensitivity in multidrug-resistant human leukemia CEM cells by inhibition of DNA-dependent protein kinase using wortmannin. Leuk. Res. 11, 917-925
18 Sartor. C. J. 2000. Biological modifiers as potential radiosensitizers: targeting the epidermal growth factor receptor family. Semin. Oncol. 27, 15-20
19 Usmani, B. A. and G. V. Sherbet. 1996. Homologous recombination in variants of the B16 murine melanoma with reference to their metastatic potential. J. Cell Biochem. 61, 1-8   DOI
20 Baselga, J. 2002. Targeting the epidermal growth factor receptor with tyrosine kinase inhibitors: small molecules, big hopes. J. Clin. Oncol. 20, 2217-2219
21 Nakajima, M., K. Kashiwagi, J. Ohta, S. Furukawa, K. Hayashi, T. Kawashima and Y. Hayashi. 1994. Nerve growth factor and epidermal growth factor rescue PC12 cells from programmed cell death induced by etoposide: distinct modes of protection against cell death by growth factors and a protein-synthesis inhibitor. Neurosci. Lett. 176, 161-164   DOI   ScienceOn
22 Milas, J., K. Mason, N. Hunter, S. Petersen, M. Yamakawa, K. Ang, J. Mendelsohn and Z. Fan. 2000. In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody. Clin. Cancer Res. 6, 701-708
23 Solorzano, C. C., C. H. Baker, R. Tsan, P. Traxler, P. Cohen, E. Buchdunger, J. J. Killion and J. J. Fidler. 2001. Optimization for the blockade of epidermal growth factor receptor signaling for therapy of human pancreatic carcinoma. Clin. Cancer Res. 7, 2563-2572
24 Walker, J. R., R. A. Corpina and J. Goldberg. 2001. Structure of the Ku heterodimer bound to DNA and its implications for double-strand break repair. Nature 412, 607-614   DOI   ScienceOn
25 Sweeney, P., T. Karashima, S. J. Kim, D. Kedar, B. Mian, S. Huang, C. Baker, Z. Fan, D. J. Hicklin, C. A Pettaway and C. P. Dinney. 2002. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production. Clin. Cancer Res. 5, 2714-2724
26 Sana, H., Y. Veda, N. Takakura, G. Takemura, T. Doi, H. Kataoka, T. Murayama, Y. Xu, T. Sudo, S. Nishikawa, S. Nishikawa, H. Fujiwara, T. Kita and M. Yokode. 2002. Blockade of platelet-derived growth factor receptor-beta pathway induces apoptosis of vascular endothelial cells and disrupts glomerular capillary formation in neonatal mice. Am. J. Pathol. 161, 135-143   DOI   ScienceOn
27 Mendelsohn, J. 1997. Epidermal growth factor receptor inhibition by a monoclonal antibody as anticancer therapy. Clin. Cancer Res. 3, 2703-2707
28 Bharti, A., S. K. Kraeft, M. Gounder, P. Pandey, S. Jin, Z. M. Yuan, S. P. Lees-Miller, R. Weichselbaum, D. Weaver, L.B. Chen, D. Kufe and S. Kharbanda. 1998. Inactivation of DNA-dependent protein kinase by protein kinase C delta: implications for apoptosis. Mol. Cell BioI. 18, 6719-6728
29 Lu, Z., G. Jiang, P. Blume-Jensen and Hunter, T. 2001. Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase. Mol. Cell BioI. 21, 4016-4031   DOI   ScienceOn
30 Liang, Y., P. Meleady, J. Cleary, S. McDonnell, L. Connolly and M. CIynes. 2001. Selection with melphalan or paclitaxel (Taxol) yields variants with different patterns of multidrug resistance, integrin expression and in vitro invasiveness. Eur. J. Cancer 37, 1041-1052   DOI   ScienceOn
31 Fan, Z., J. Baselga, H. Masui and J. Mendelsohn. 1993. Antitumor effect of anti-epidermal growth factor receptor monoclonal antibodies plus cis-diamminedichloroplatinum on well-established A431 cell xenografts. Cancer Res. 53, 4637-4642
32 Schmidt, M and R B. Lichtner. 2002. EGF receptor targeting in therapy-resistant human tumors. Drug Resist. Updat. 5, 11-18   DOI   ScienceOn
33 Huang. S. M. and P. M. Harari. 2000. Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis. Clin. Cancer Res. 6, 2166-2174
34 Bandyopadhyay, D., M. MandaI, J. Adam, J. Mendelsohn and R Kumar. 1998. Physical interaction between epidermal growth factor receptor and DNA-dependent protein kinase in mammalian cells. J. BioI. Chem. 273, 1568-1573   DOI   ScienceOn